VRTX

518.0050.51%
RK

Reshma Kewalramani

CEO, President & Director

Dr. Reshma Kewalramani, M.D., FASN, was Director at Year Up Inc. since September 2023. She had been an Independent Director of Ginkgo Bioworks Holdings, Inc. (formerly known as Ginkgo Bioworks, Inc.) since September 2021 until June 13, 2024. She serves on the Biomedical Science Careers Program's board of directors, the Massachusetts General Hospital board of trustees. She has been the Chief Executive Officer and President of Vertex Pharmaceuticals Incorporated since April 1, 2020 and serves as its Director since February 13, 2020. Dr. Kewalramani served as the Chief Medical Officer and Executive Vice President of Global Medicines Development and Medical Affairs at Vertex Pharmaceuticals Incorporated since April 1, 2018 until March 31, 2020. Dr. Kewalramani served as Senior Vice President of Clinical Development and Medical Affairs at Vertex Pharmaceuticals Incorporated from 2017 to March 31, 2018. She joined Vertex in 2017. Dr. Kewalramani leads the Cystic Fibrosis and General Medicine Clinical Development therapeutic areas, Clinical Development Execution, Medical Writing and Medical Affairs. Prior to Vertex, Dr. Kewalramani spent at Amgen Inc., since August 2004 until January 2017 where she held a variety of roles across Research and Development, including as Vice President Global Clinical Development, Nephrology & Metabolic Therapeutic Area and Vice President, US Medical Organization, a group she established and grew to assume responsibility for the full portfolio of molecules across six therapeutic areas. From 2014 through 2019, Dr. Kewalramani is the industry representative to the FDA’s Endocrine and is on the Board of Directors of the Kidney Health Initiative. She completed her internship and residency in Internal Medicine at the Massachusetts General Hospital and her fellowship in Nephrology at the Massachusetts General Hospital and Brigham and Women’s Hospital combined program. Dr. Kewalramani has a B.A. from Boston University and an M.D. from Boston University School of Medicine. Dr. Kewalramani also completed the General Management Program at Harvard Business School and is an alumnus of the school.

Positions